STOCK TITAN
  1. Home
  2. Sec-filings
  3. GEHC
  4. [Form 4] GE HealthCare Technologies Inc. Insider Trading Activity

GE HealthCare exec has 1,064 shares withheld

An executive of GEHC had shares withheld to cover taxes on vested RSUs, leaving a reported 37,293 shares held directly.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

GE HealthCare Technologies Inc. (GEHC) reported that Jeannette Bankes, CEO, Patient Care Solutions, had 1,064 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations arising from the vesting of restricted stock units. After this tax-withholding disposition, she holds 37,293 shares of GE HealthCare common stock directly, and no Rule 10b5-1 plan is reported.

Positive

  • None.

Negative

  • None.
Insider Bankes Jeannette
Role CEO, Patient Care Solutions
Type Security Shares Price Value
Tax Withholding Common Stock, par value $0.01 per share F1 1,064 $71.23 $76K
Holdings After Transaction: Common Stock, par value $0.01 per share — 37,293 shares (Direct)
Footnotes (1)
  1. F1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Shares withheld for taxes 1,064 shares Shares of GE HealthCare common stock withheld on September 1, 2026 for tax withholding obligations
Price per share for tax withholding $71.23 per share Valuation used for the 1,064 shares withheld on September 1, 2026
Shares held after transaction 37,293 shares Direct holdings of Jeannette Bankes after the September 1, 2026 tax-withholding disposition
restricted stock units financial
"in connection with the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"to satisfy tax withholding obligations in connection with the vesting"
withholding of shares financial
"Withholding of shares of GE HealthCare Technologies Inc. common stock"

FAQ

What insider transaction did GEHC report for Jeannette Bankes on this Form 4?
GE HealthCare Technologies Inc. reported that Jeannette Bankes had 1,064 shares of common stock withheld on September 1, 2026 to satisfy tax withholding obligations related to the vesting of restricted stock units.

Did the GEHC Form 4 report an open-market buy or sell by Jeannette Bankes?
No. The Form 4 reports a code F transaction, meaning 1,064 shares were withheld to pay tax liabilities on vested restricted stock units, not an open-market purchase or sale.

How many GEHC shares did Jeannette Bankes hold after the reported transaction?
After the September 1, 2026 tax-withholding transaction, Jeannette Bankes is reported to hold 37,293 shares of GE HealthCare Technologies Inc. common stock directly.

What price per share was used for the GEHC tax-withholding transaction?
The tax-withholding disposition of 1,064 shares of GE HealthCare common stock was reported at a price of $71.23 per share, which is used to value the shares withheld for tax obligations.

Was the GEHC insider transaction made under a Rule 10b5-1 trading plan?
No. The filing’s Rule 10b5-1 checkbox is not marked as affirming a plan, and there is no footnote stating that the September 1, 2026 tax-withholding transaction was executed under a Rule 10b5-1 trading arrangement.

Who is the reporting person in the GEHC Form 4 and what is their role?
The reporting person is Jeannette Bankes, who is identified as an officer of GE HealthCare Technologies Inc. with the title CEO, Patient Care Solutions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Bankes Jeannette
(Last)(First)(Middle)
500 WEST MONROE STREET
(Street)
CHICAGO ILLINOIS 60661
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
GE HealthCare Technologies Inc. [ GEHC ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
CEO, Patient Care Solutions
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock, par value $0.01 per share09/01/2026F1,064(1)D$71.2337,293D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
Remarks:
/s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact09/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR